Kirov Research Institute of Hematology and Blood Transfusion

Kirov 610027

0 studies enrolling now · 3 studies all time

What they study most

Hemophilia A, Hemophilia A With Inhibitor, Hemophilia A With Inhibitors, Hemophilia B With Inhibitor, Hemophilia B With Inhibitors

Studies at this site

• Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B — Stopped early
• Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors — Completed
• Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A — Status unconfirmed